We're committed to a clean and safe facility. Submit your health declaration
8585 S. Knott Ave, Suite #101, Buena Park, CA 90620
Tel: 714-821-8588
What is EECP?
What is EECP?
EECP therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina/coronary artery disease and heart failure. EECP therapy has helped thousands of patients. In fact, clinical studies show that over 75% of patients benefit from EECP therapy and sustain improvement for up to three years post- treatment.
​
EECP therapy works by increasing the blood and oxygen supply to the heart muscle and decreasing the amount of work the heart must do to pump blood to the rest of the body. While the heart is at rest, treatment cuffs inflate from the calves to the thighs to the buttocks, which increases the blood supply to the arteries feeding the heart muscle. Just before the next heartbeat, all the cuffs simultaneously deflate, decreasing the heart’s workload.
EECP vs Angioplasty with Stent
CAD is a chronic inflammatory disease commonly treated with invasive coronary revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG). Both procedures are aimed at relieving patients’ symptoms, but do not cure CAD or even prevent heart attacks. Enhanced external counterpulsation (EECP) is offered as a non-invasive alternative to revascularization procedures.
During EECP the blood flowing to your heart will naturally bypass arteries with significant plaque, and instead enter healthy, non-diseased blood vessels, circumnavigating blockages. In time, these new pathways are reinforced and become lasting routes for blood to reach your heart beyond the blockages. This is why EECP is often referred to as a “natural bypass.”
Indications for EECP (CMS Guidelines)
EECP candidates include patients with angina pectoris responding inadequately to anti-ischemic agents and coronary revascularization, who are inoperable or at high risk for operative complications or postoperative failure, who are poor candidates for PCI or CABG, or continue to have disabling angina despite revascularization.
​
​